MALOBERTI ALESSANDRO

Tognola, C., Bernasconi, D., Rebora, P., Intravaia, R., Mancusi, C., Visco, V., et al. (2026). Inflammatory biomarkers relationship with major adverse cardiovascular events and hypertensive-mediated organ damage, in subjects without established cardiovascular disease. AMERICAN JOURNAL OF PREVENTIVE CARDIOLOGY [10.1016/j.ajpc.2026.101640]. Dettaglio

Fragoulis, C., Maloberti, A., Boulestreau, R., De Backer, T., Doumas, M., Fucile, I., et al. (2026). Gaps between guidelines and practice in hypertensive urgencies and emergencies: data from a multinational European registry in ESH excellence centres. JOURNAL OF HYPERTENSION, 44(4), 609-620 [10.1097/HJH.0000000000004231]. Dettaglio

Vallelonga, F., Cesareo, M., Sanapo, M., Colombo, B., Maloberti, A., Fucile, I., et al. (2026). “Short-term prognosis of hypertensive emergencies and urgencies: second preliminary report of the ongoing Italian multicenter ERIDANO study”. HYPERTENSION RESEARCH [10.1038/s41440-026-02586-9]. Dettaglio

Brucato, F., Tognola, C., Moreo, A., Bellomare, M., Prencipe, G., Lettino, M., et al. (2026). Eligibility for Icosapent ethyl in patients undergoing cardiac rehabilitation: A real-world cohort study. INTERNATIONAL JOURNAL OF CARDIOLOGY, 445(February 15, 2026), 1-6 [10.1016/j.ijcard.2025.134046]. Dettaglio

Intravaia, R., Tognola, C., Maloberti, A., Brucato, F., Campione, E., Giannattasio, C., et al. (2026). The role of inflammation in acute coronary syndrome: A systematic review on biochemical inflammatory assessment and anti-inflammatory therapies. NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 36(2) [10.1016/j.numecd.2025.104409]. Dettaglio